Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TolaSure Gel in Epidermolysis Bullosa Simplex
NCT07027345Phase 2Recruiting
- Sponsor
- BioMendics
- Start
- Sep 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TolaSure Vehicle Gel in epidermolysis bullosa simplex (EBS), sponsored by BioMendics. Started Sep 2025; status: recruiting.
02
Drugs
TolaSure Vehicle Gel
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on NCT07027345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07027345.